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Abstract 
 
In this article, we report on a systematic review of the literature on pressure-pain thresholds 
induced and assessed by computerized cuff pressure algometry (CPA). The motivation for this review 
is to provide design guidance on pressure levels for wearable soft exoskeletons and similar wearable 
robotics devices. 
In our review, we focus on CPA studies of patients who are candidates for wearable soft 
exoskeletons, as pain-related physiological mechanisms reportedly differ significantly between 
healthy subjects and patients with chronic pain. The results indicate that circumferential limb 
compression in patients most likely becomes painful at approximately 10-18 kPa, and can become 
unbearable even below 25 kPa. The corresponding ranges for healthy control subjects are 20-42 kPa 
(painful limits) and 34-84 kPa (unbearable levels).  Also, the increase of pain with time tends to be 
significantly higher, and the adaptation to pain significantly lower, than in healthy subjects. The 
results of this review provide guidance to designers of wearable robotics for populations with 
chronic pain regarding rates and magnitudes of tissue compression that may be unacceptable to 
users.   
1. Introduction 
 
A variety of pathologies impair human gait by reducing the ability to control the lower limbs, which 
gives rise to the opportunity for gait-assistive devices. Recent developments have focused on 
developing wearable robots to assist with walking, including by way of lower limb exoskeletons. 
Typically, exoskeletons are composed of rigid materials that impart torque assistance to human 
joints, but recently, lighter, low-profile soft exoskeletons or exosuits1 are being developed from 
materials, such as textiles. The physical interaction between soft exoskeletons and the user will 
typically involve application of circumferential forces to the user’s limbs via connection cuffs.2 The 
growing use of exoskeletons, especially among individuals with various neurological conditions, is 
increasing the importance of ethics in robotics, and the need to ensure user safety. There is, 
however, a lack of guidance for the design of safe human-device interfaces regarding mechanical 
loading of the user’s body, especially for the new generation of soft exoskeletons. 
 
As excessive mechanical loading can lead to soft tissue injury, attempts have been made to establish 
safe thresholds for the external mechanical loading of tissues. These thresholds have been based on 
interface pressures at load-bearing sites of the body, but recent studies have shown that the 
relationship between interface pressure and internal stress is not linear.3 Internal stress is highly 
dependent on the nature of the intervening soft tissues, e.g. their thickness,4,5 tone,5,6 mechanical 
stiffness,7 and integrity,5 as well as the proximity of bony prominences.4,5,7,8 Moreover, injury 
thresholds differ for skin, adipose tissue and muscle, with the lowest threshold for muscle.8 Thus a 
safe threshold based solely on interface pressure is not acceptable.3,7-9 Because measurement of 
internal pressure is technically and ethically challenging,3 several other techniques have been used in 
combination with interface pressure measurements. 
 
The authors propose that pain and discomfort studies using pressure algometry could be a relevant 
approach to study tissue exposures to mechanical stress for soft robotics applications and wearable 
robots generally, as pain is the most direct reaction of the human body to excessive external loads.10 
Moreover, pressure-induced muscle pain is mainly related to strain,11 and is considered a good 
indicator of potential tissue damage caused by excessive pressure exposures.12 
 
In a previous review,13 we proposed that the findings of studies on computerised pneumatic Cuff 
Pressure Algometry (CPA) be used to establish indicative guidelines for acceptable levels of 
mechanical tissue compression in humans using wearable robots. CPA assesses the response of large 
volumes of deep somatic tissues to compression,11,14-16 as induced by soft exoskeletons, and is a 
reliable method for quantitative sensory measurements and evaluation of central sensitisation.16-23 
Typically, two parameters of pain sensation are measured with algometry: the pressure magnitude 
at which pain occurs (Pain Detection Threshold – PDT), and the pressure magnitude that causes 
unbearable pain (Pain Tolerance Threshold – PTT).13 
 
Our previous review13 focused on healthy subjects’ pain thresholds, induced by CPA at the lower 
limb. We found that the mean PDTs ranged from 14-34 kPa and the mean PTTs from 37-91 kPa. 
However, pressure-pain thresholds (PPTs) and pain-related physiological mechanisms differ 
significantly between healthy subjects and patients with chronic pain. We are unaware of any prior 
review studies of the corresponding values for patients, especially those with chronic pain. 
 
Chronic pain has been recognized as pain that persists past normal healing time, usually more than 3 
to 6 months,24 and hence lacks the acute warning function of physiological nociception.25 Among the 
most widely studied subgroup of patients presenting with chronic widespread pain are patients with 
Fibromyalgia Syndrome (FMS).19 Chronic pain is also common in Rheumatoid Arthritis (RA).23 In older 
adults, chronic pain is common,26 and is found to be associated with an increased risk and intensity 
of frailty.27-29 Highly prevalent painful conditions at older age, such as Osteoarthritis (OA) are related 
to disability,30,31 especially mobility limitations associated with impairments in balance and gait.32-35 
Finally, chronic pain is estimated to occur among 40-67 % of patients after Spinal Cord Injury (SCI),36-
39 who are the target users of many wearable gait-assistive devices. 
 
Clinical studies have demonstrated that patients with chronic pain exhibit hyperalgesia to 
mechanical stimulation,15,23,40,41 even when the stimulus is applied at an unaffected site (generalised 
hyperalgesia),35 and even after the primary cause of pain has disappeared.17,23,35,42 Namely, 
persistent pain can cause changes in the facilitation and/or inhibition of pain by the central nervous 
system, that can significantly modulate the efficacy of signal transfer at spinal synapses and thus the 
experience of pain (descending pain modulation; Figure 1).43 These changes can lead to central 
sensitisation, i.e. spinal hyperexcitability,44, that may involve an imbalance between the descending 
pain-modulatory systems, as well as reorganisation of the higher brain centres.35 
 
 
 Figure 1: Descending pain modulation. 
 
Central sensitisation results in reduced pain thresholds and pain amplification;45 however, pressure-
pain thresholds alone do not differentiate between central and peripheral sensitisation.23 Therefore, 
additional tests are used to evaluate changes in central pain modulation that result in generalised 
hypersensitivity. 
 
Spatial and temporal summation of pain are normal phenomena, and their magnitude depends on 
descending pain-facilitating systems,46,47 therefore they are used for examinations of central pain 
facilitation.21,35,45,47-50 Spatial Summation of Pain (SSP) is defined as an increased perception of pain 
at the same magnitude of mechanical stimulation when larger, compared with smaller areas of body 
tissue are stimulated (Figure 2a).51,52  This explains why pain is induced at lower pressures when 
compression is performed at the lower limb compared to the upper limb, and with wide compared 
to narrow pressure cuffs. 
Temporal Summation of Pain (TSP) is defined as gradually increasing perception of pain that occurs 
when a series of identical painful stimuli is applied with a frequency above 0.3 Hz (Figure 2b).16,45,53-56 
A typical protocol of mechanically painful stimulation for evaluation of TSP is 10 repeated stimuli 
with 1-second inter-stimulus interval.42 The stimulation intensity and the initial stimulus being 
painful are important for evoking TSP.57 
 
 
 Figure 2: The mechanism of (a) Spatial Summation of Pain (SSP) and (b) Temporal Summation of Pain 
(TSP). 
 
In the case of central sensitisation, SSP and TSP are facilitated, i.e., the perceived pain increases 
more prominently (SSP) or rapidly (TSP) with the applied stimuli (Figure 3). Facilitated SSP is found in 
patients with knee OA,49 and facilitated TSP in patients with chronic painful OA,41 FMS,58 and 
whiplash-associated disorder.59 
 
 
 
Figure 3: Pain intensity at (a) facilitated Spatial Summation of Pain (SSP) and (b) facilitated Temporal 
Summation of Pain (TSP) in patients with chronic pain. 
 
A particular form of descending pain-inhibitory systems is the Conditioned Pain Modulation (CPM). 
In contrast to the pain-increasing effects of SSP and TSP, CPM results in reduced pain sensitivity in 
healthy subjects16 when two painful stimuli are applied simultaneously (the ‘pain inhibits pain’ 
paradigm).35,60-63 The testing of CPM is used to address the complex balance between the descending 
inhibition and facilitation of nociceptive processing64 and the transition from acute to chronic pain.65 
The general recommendation for testing is to use extra-segmental or contralateral sites, such as the 
upper arm and lower leg.66,67 Previous studies have concluded that CPM is impaired in OA of the 
hip68 and knee,41 in temporomandibular disorders,69 in fibromyalgia,70 and with increasing age.62,71 
 
This study is a systematic review of the literature on pressure-induced pain, as established by CPA, 
specifically in patients with chronic pain. We believe that CPA-parameters can help identify the 
acceptable mechanical stress applied by gait-assistive robotic devices, in order to avoid user 
discomfort and soft-tissue damage. We also believe that patients with chronic pain are an important 
group of potential users of such devices, due to the mobility impairments often associated with their 
medical conditions. The purpose of this review is to gain insight into the acceptable levels of external 
pressure for soft robotic devices, as design guidance for potential patient end users. 
 
  
2. Method 
 
2.1. Literature Search and Study Selection 
A systematic literature search was performed in May 2017, using the following databases: Academic 
Search Complete, AMED, Biomedical Reference Collection: Expanded, CINAHL®Complete, CINAHL 
Plus® with Full Text, General Science Full Text™, MEDLINE, PsycARTICLES®, PsycINFO®, Scopus, and 
SPORTDiscus with Full Text. The keywords used to identify articles of interest were "cuff”, 
“algometry" and "patient". Results not reporting on quantitative sensory testing performed by cuff 
algometry, or not including patients with chronic pain were excluded. Figure 4 illustrates the search 
and screening process. A second reviewer repeated the search and screening process to ensure that 
the process was accurate and repeatable. 
 
2.2. Data Extraction and Synthesis 
Data extracted from the selected studies included: 1) the patients' characteristics (age, sex, 
anthropometric characteristics and medical condition), 2) the assessment methods (tourniquet cuff 
characteristics and positioning, compression rates and durations, pain-intensity rating, etc.), 3) the 
variables studied, and 4) the findings of the study. 
 
The relevant independent variable was pneumatic cuff inflation pressure, and the relevant 
dependent variables were PDT and PTT. Other variables, especially TSP and CPM were also studied, 
but were not a filter criterion for inclusion in the review. 
 
  
Figure 4: Literature search and study selection 
 
  
3. Results 
 
3.1. Participants 
The search identified 18 relevant studies, 7 of which also included healthy controls.15,21,49,50,59,72,73 
Four studies were of patients with chronic widespread pain or fibromyalgia,15,19,59,74 8 studies were of 
patients with osteoarthritis,22,49,73,75-79 and then individual studies were of patients with rheumatoid 
arthritis,50 chronic musculoskeletal pain,80 chronic back pain,81 chronic pain of different etiologies,82 
lateral epicondylalgia,21 and patellofemoral pain.72 Six studies included only females,15,21,50,59,72,74 and 
the remaining 12 studies involved both male and female participants. The mean age of participants 
was 60+ years in 8 studies,22,49,73,75-79 and under 40 years of age in 4 studies.21,50,59,72 Fourteen studies 
reported the mean BMI19,21,22,73-81 or the weight and height59,72 of the participants, and two studies 
reported the mean circumference of the limb studied.15,59 
 
3.2. Assessment methods 
All studies were performed on the lower leg, and 2 also on the upper limb.21,59 CPA was performed 
using a 13 cm wide double-chamber tourniquet cuff in 15 studies, 6 studies additionally used only 
one chamber to assess SSP,21,49,59,78,79 and one also used a single-chamber tourniquet.73 Three 
studies22,50,77 did not describe the tourniquet cuff used. 
 
Participants in all studies rated their pressure-induced pain intensity on an electronic Visual 
Analogue Scale (VAS), with 0 indicating “no pain” and 10 cm “maximal pain”. All ratings were 
recorded at 10 Hz. PDT was defined as the inflation-pressure magnitude when the rating on VAS 
either exceeded 0 cm,15,19,21,49,50,59 was equal to 1 cm,72,75,80,82 or exceeded 2 cm.73,76,81 5 studies did 
not explicitly define the rating on the VAS when PDT occurs.22,74,77-79 
 
In 8 studies, single-point pressure algometry was performed in addition to CPA.49,72,73,75,76,78-80 
Other tests were performed in some studies, such as assessment of maximal isokinetic muscle 
strength,15,80 manual tender point examination and tender point count,15,19 myalgic score,15 
questionnaires to assess depression, anxiety, and pain catastrophizing,15,19 self-reporting of 
somatosensory symptoms of neuropathic pain,19 thermal pain sensitivity,81,82 exercise-induced 
hypoalgesia,75,80 cold-pressor test,75,80 and provocation tests with hypertonic saline solution,59 but 
these are beyond the scope of this systematic review. 
 
 
3.3. Variables studied 
The current review was primarily of PDT and PTT considering the context of soft-robotics/soft 
exoskeleton applications. 4 studies reported only PDTs,22,49,77,79 and the remainder both PDTs and 
PTTs. 4 studies also assessed Spatial Summation of Pain (SSP),21,49,59,79 13 studies Temporal 
Summation of Pain (TSP),21,22,50,59,72,73,76-82 and 8 studies Conditioned Pain Modulation 
(CPM).40,72,73,76,78,79,81,82 
 
9 studies reported the results in the form of Mean ± SD and 9 studies as Mean ± SEM. 5 
studies49,72,73,76,78 only presented the results graphically, and in those instances the data were scaled 
and rounded to the closest whole number. 
 
3.4. Findings 
The studies reviewed are summarized and ordered chronologically in Table 1. The key mean values 
are rounded to the closest whole number and compared in Table 2. 
 
Patients with chronic pain show significantly decreased pressure-induced pain thresholds on the 
lower leg compared to healthy participants.15,21,49,50,59,73,78 When using both chambers of a double-
chambered cuff at the lower leg, mean PDT ranged from 8.8 kPa19 to 34 kPa49 in patients (and 16 
kPa73 to 37 kPa72 in healthy controls), but 19 of the 28 mean PDT levels that were assessed across 
the studies in patients were under 20 kPa (median across the studies was 17.9 kPa). Mean PTT levels 
ranged from 23 kPa76 to 75 kPa72 in patients (and 34.2 kPa73 to 84 kPa72 in healthy controls), with 14 
of the 24 assessed mean PTT levels for patients under 40 kPa (median across the studies was 38 
kPa). For the upper limb, the mean PDT levels ranged from 18.8 kPa59 to 25.3 kPa21 in patients (and 
24.9 kPa59 to 36.8 kPa21 in healthy controls), and mean PTT levels from 47.9 kPa59 to 76.1 kPa21 in 
patients (and 65.7 kPa59 to 90.5 kPa21 in healthy controls). PDTs and PTTs were significantly higher 
for the upper limb than the lower limb when compared within the same individuals in one study.59 
Despite the different pressure levels at PTT, no significant difference in pain rating on the VAS at PTT 
was found between patients and healthy controls, suggesting similar experience of pain intensity at 
the point where pain becomes unbearable.15,59 
 
TSP in patients ranged from normal72 to facilitated,50,59,73 and CPM ranged from preserved59,78 to 
impaired.72,78 A higher degree of TSP was found in patients with longer lasting pain.21 Significantly 
higher PDT and PTT were found during single-chamber compression compared to double-chamber 
compression, indicating SSP.59,78 One study only found significant SSP in healthy controls, but not in 
patients.21 Age was found to correlate significantly negatively with pressure-pain thresholds but not 
TSP or CPM, indicating that increasing age may mainly affect the peripheral nociceptive system and 
to a lesser extent the central nociceptive mechanisms.73 
 
Single-point algometry results showed significant differences in PPTs in relation to testing site: PPTs 
on the affected side were significantly lower than contralaterally.21,49 
 
  
Reference Participants Experimental Procedure Variables Findings 
Jespersen et al. 
(2007)15 
Patients with fibromyalgia: 
48 female 
- Age: median 49 years, range 
22-60 years 
- Circ.: 37.4 ± 0.5 cm 
 
Healthy controls: 
16 female 
- Age: median 45 years, range 
25-60 years 
- Circ.: 35.7 ± 1.0 cm 
 
n = 64 
 
A) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- dominant lower leg  
- inflation rate: 0.5 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(PDT: VAS > 0) 
- supine position 
 
B) Maximal isokinetic knee muscle strength 
C) Tenderpoints and myalgic score 
D) Depression, symptoms and functions 
Independent: 
Pneumatic cuff inflation pressure 
 
Dependent: 
Pressure-Pain Threshold (PDT) 
Pressure-Pain Tolerance (PTT) 
Pressure-Pain Limit (VAS at PTT) 
Pain thresholds (Mean ± SEM): 
 Patients Controls 
PDT (kPa) 15.4 ± 1.1 19.9 ± 2.2 
PTT (kPa) 34.0 ± 2.3 43.7 ± 4.2 
VAS at PTT (cm) 8.8 ± 4.5 9.4 ± 2.2 
 
PDT and PTT were significantly lower in patients compared to healthy 
controls. No significant difference in VAS at PTT between patients and 
healthy controls was found. 
No significant correlation was found between leg circumference and 
pressure-pain thresholds. CPA-parameters were significantly correlated 
to isokinetic muscle strength. 
 
Amris et al. 
(2010)19 
Patients with chronic 
widespread pain (fibromyalgia): 
75 female, 6 male 
- Age: 45.7 ± 10.9 years 
- BMI: 28.3 ± 5.9 kg/m2 
 
n = 81 
A) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- dominant lower leg  
- inflation rate: 1 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(PDT: VAS > 0) 
- supine position 
 
B) Self-reporting of somatosensory symptoms of neuropathic pain 
C) Self-reporting of depression, anxiety, and pain catastrophizing 
D) Manual tender point examination and tender point count 
 
Independent: 
Pneumatic cuff inflation pressure 
 
Dependent: 
PDT 
PTT 
Pain thresholds (Mean ± SD):  
PDT (kPa) 8.8 ± 6.0 
PTT (kPa) 30.9 ± 17.5 
 
Lemming et al. 
(2012)59 
Patients with chronic 
widespread pain: 
25 female 
- Age: 36 years (SEM 1.3) 
- Weight: 68.3 kg (SEM 2.9) 
- Height: 166 cm (SEM 1.0) 
- Circ.: 38 cm (SEM 0.7) 
Healthy controls: 
10 female 
- Age: 41 years (SEM 2.0) 
- Weight: 66.9 kg (SEM 2.2) 
- Height: 168 cm (SEM 2.0) 
- Circ.: 38 cm (SEM 0.6) 
 
n = 35 
 
A) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- lower leg around the midportion of m. triceps surae 
and arm at the level of the heads of mm. biceps and triceps brachii 
- inflation rate: 1 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(PDT: VAS > 0) 
- 3 repetitions 
Assessment: 
SSP: random inflations of:  A1) single chamber 
   A2) both chambers 
TSP: tonic 10-minute stimulation: 1) at 25 kPa 
 2) at (PDT+PTT)/2 intensity 
- 2 repetitions, separated by 7 minutes 
- calculation of maximal VAS, time to maximal VAS, area under 
the time-VAS curve and TS-index 
 
B) Saline-induced muscle and referred pain 
 
Independent: 
Pneumatic cuff inflation pressure 
 
Dependent: 
PDT 
PTT 
PTI 
SSP 
TSP 
Pain thresholds (Mean ± SEM): 
 
Arm Lower leg 
Double cuff Single cuff 
Patients 
PDT (kPa) 18.8 ± 2.3 18.1 ± 1.9 23.4 ± 3.4 
PTT (kPa) 47.9 ± 4.5 38.9 ± 3.5 52.3 ± 5.4 
PTI (cm) 9.7 ± 0.1 9.5 ± 0.2 9.5 ± 0.2 
Controls 
PDT (kPa) 24.9 ± 5.6 23.3 ± 2.6 28.9 ± 4.8 
PTT (kPa) 65.7 ± 6.2 49.5 ± 4.2 62.2 ± 6.3 
PTI (cm) 9.8 ± 0.2 9.7 ± 0.2 9.7 ± 0.2 
 
PTT with double cuff was significantly higher in controls than in patients 
both in the leg and arm. PDT and PTI did not differ significantly 
between the two groups in arm (double cuff) or leg (both cuffs). 
SSP: At the leg, PDT and PTT were significantly higher during single cuff 
stimulation compared with double cuff stimulation. No significant 
differences in pressure-pain thresholds between single and double cuff 
were found between controls and patients. 
TSP: TSI and VASpeak were significantly higher and the time to VASpeak 
significantly shorter in patients than in controls. One-third of the 
patients and 4 controls exhibited habituation to pain.  
 
Reference Participants Experimental Procedure Variables Findings 
Graven-Nielsen 
et al. (2012)49 
Patients with knee OA: 
36 female, 12 male 
- Age: mean 65 years, range  
40–86 years 
Healthy controls: 
17 female, 4 male 
- Age: mean 60 years, range 
40–81 years 
 
n = 69 
A) Single-point pressure algometry (hand-held): 
- 1 cm2 probe 
- test sites: 
A1) peripatellar region (7 sites) 
A2) m. tibialis anterior 
A3) m. extensor carpi radialis longus 
- 2-3 repetitions 
 
B) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- lower leg around the midportion of m. gastrocnemius–soleus 
- inflation rate: 1 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(PDT: VAS > 0) 
- 3 repetitions 
Assessment: 
SSP: 
- random inflations of: 
B1) single chamber 
B2) both chambers 
CPM: 
- conditioning stimulus: 
inflation of 7.5 cm wide cuff to 200 mmHg for 10 minutes 
arm, ipsilateral to the painful knee 
- test stimulus: 
single-point algometry at VAS = 4 cm 
CPA at VAS = 4 cm 
Independent: 
Probe pressure 
Pneumatic cuff inflation pressure 
 
Dependent: 
PPT 
Cuff PPT 
SSP 
CPM 
Pain thresholds (Mean ± SEM): 
 
A) Single-point algometry - pain thresholds, as established from the 
provided charts: 
 Patients Controls 
affected contralateral affected contralateral 
PPT (kPa) A1 317 ± 18 348 ± 17 400 ± 17 360 ± 20 
244 ± 16 296 ± 16 356 ± 15 351 ± 18 
269 ± 17 311 ± 19 382 ± 14 386 ± 18 
201 ± 15 246 ± 21 263 ± 16 252 ± 23 
222 ± 13 275 ± 20 349 ± 13 336 ± 17 
240 ± 13 289 ± 21 340 ± 13 317 ± 18 
252 ± 19 284 ± 19 353 ± 12 330 ± 15 
A2 243 ± 15 269 ± 23 376 ± 15 367 ± 21 
A3 227 ± 14 257 ± 23 352 ± 12 351 ± 22 
 
B) CPA: 
 Patients Controls 
affected contralateral affected contralateral 
Cuff PPT 
(kPa) 
B1 32.9 ± 2.0 34.0 ± 2.2 40.4 ± 3.6 41.9 ± 4.3 
B2 25.2 ± 1.6 27.2 ± 1.8 34.5 ± 2.7 35.3 ± 3.0 
 
PPTs in patients were significantly lower than in controls. PPTs on the 
affected side in patients were significantly lower than contralaterally. 
PPTs at different test sites differed significantly. 
 
Jespersen et al. 
(2013)21 
Patients with lateral 
epicondylalgia: 
22 female 
- Age: median 43 years, range  
39 years 
- BMI: 26.2 ± 5.9 kg/m2 
Pain-free controls: 
38 female 
- Age: median 39 years, range  
25 years 
- BMI: 23.9 ± 3.6 kg/m2 
 
n = 60 
 
CPA: 
- double-chamber tourniquet cuff (width 13 cm): 
length 61 cm: lower leg around the widest part of m. gastrocnemius 
length 13 cm: lower arm over the extensor region 
- inflation rate: 1 kPa/s 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(PDT: VAS > 0) 
- 3 repetitions 
Assessment: 
SSP: 
- lower leg 
- random inflations of: 
1) single chamber 
2) both chambers 
TSP: 
- tonic 10-minute stimulation at (PDT+PTT)/2 intensity 
- TS-index was calculated 
Independent: 
Probe pressure 
Pneumatic cuff inflation pressure 
 
Dependent: 
PDT 
PTT 
VAS at PTT 
SSP 
TSP 
Pain thresholds (Mean ± SEM): 
 
Lower arm Lower leg 
Double cuff Single cuff 
Patients 
PDT (kPa) 25.3 ± 4.1 21.1 ± 2.4 22.6 ± 3.3 
PTT (kPa) 76.1 ± 7.3 51.0 ± 4.1 61.9 ± 5.5 
VAS at PTT (cm) NA 8.2 ± 0.4 8.4 ± 0.4 
Controls 
PDT (kPa) 36.8 ± 4.6 24.9 ± 2.0 36.2 ± 3.6 
PTT (kPa) 90.5 ± 5.8 56.0 ± 3.2 79.8 ± 4.4 
VAS at PTT (cm) NA 8.1 ± 0.4 8.2 ± 0.4 
 
Significantly lower PDT and PTT were found in patients compared to 
controls on the lower leg. In patients, PDT was significantly lower on 
the affected side. 
SSP: A significantly lower PDT was found in controls when increasing 
stimulation area, but not in patients. 
TSP: A higher degree of TSP was found in patients with longer lasting 
pain. 
 
Reference Participants Experimental Procedure Variables Findings 
Skou et al. 
(2013)79 
Patients with knee OA: 
4 female, 13 male 
- Age: 65.1 ± 7.9 years 
- BMI: 29.7 ± 5.6 kg/m2 
 
n = 17 
A) Single-point pressure algometry (hand-held): 
- 1 cm2 probe 
- test sites:  A1) peripatellar region (8 sites) 
  A2) m. tibialis anterior 
 
B) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- lower leg at the level of the heads of m. gastrocnemius 
- inflation rate: 0.5 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
- 2 repetitions 
Assessment: 
SSP: 
- inflation of:  B1) proximal chamber only 
  B2) distal chamber only 
  B3) both chambers 
TSP: 
- 10 repeated stimulations: 1 s of (Cuff PPT + Cuff PTT)/2 intensity, 1 
s of 5 kPa 
CPM: 
- conditioning stimulus: inflation of 7.5 cm wide cuff to constant 
pressure (4 cm VAS) at the left arm 
- test stimulus: single-point algometry 
 
Independent: 
Probe pressure 
Pneumatic cuff inflation pressure 
 
Dependent: 
PPT 
Cuff PPT 
Cuff PTT 
SSP 
TSP 
CPM 
Pain thresholds (Mean ± SD): 
PPT (kPa) A1 469 ± 349 
A2 419 ± 252 
Cuff PPT (kPa) 8.92 ± 4.68 
 
Significant positive correlations between various pressure pain 
threshold measures and temporal summation from the knee and 
tibialis anterior were found. 
Skou et al. 
(2013)78 
Patients with end-stage knee OA 
after revision-TKA: 
20 with pain (P): 
14 female, 6 male 
- Age: 61.5 ± 1.8 years 
- BMI: 30.7 ± 1.2 kg/m2 
20 pain-free (NP): 
8 female, 12 male 
- Age: 65.7 ± 1.3 years 
- BMI: 31.5 ± 0.9 kg/m2 
 
n = 40 
A) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- lower leg at the level of the heads of m. gastrocnemius 
- inflation rate: 1 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
Assessment: 
PPT, PDT: 
- 2 random inflations of: 
A1) proximal chamber only 
A2) distal chamber only 
A3) both chambers 
TSP: 
- 10 repeated stimulations: 1 s of (PPT+PTT)/2 intensity, 1 s of 5 kPa 
CPM: 
- conditioning stimulus: 
inflation of 7.5 cm wide cuff to constant pressure (4 cm VAS) 
left arm 
- test stimulus: 
single-point algometry 
before, during and 5 minutes after conditioning 
 
B) Single-point pressure algometry (hand-held) 
Independent: 
Pneumatic cuff inflation pressure 
 
Dependent: 
PPT 
Cuff PPT 
Cuff PTT 
TSP 
CPM 
Baseline pain thresholds, as established from the provided charts 
(Mean ± SEM): 
 
A1) Proximal chamber only 
 P NP 
Cuff PPT 
(kPa) 
Revised side  12 ± 2 19 ± 5 
Contralateral side 12 ± 2 18 ± 5 
Cuff PTT 
(kPa) 
Revised side  32 ± 4 53 ± 7 
Contralateral side 34 ± 5 50 ± 6 
 
B2) Distal chamber only 
 P NP 
Cuff PPT 
(kPa) 
Revised side  11 ± 2 16 ± 3 
Contralateral side 10 ± 1 15 ± 3 
Cuff PTT 
(kPa) 
Revised side  28 ± 3 40 ± 5 
Contralateral side 27 ± 3 41 ± 4 
 
A3) Both chambers 
 P NP 
Cuff PPT 
(kPa) 
Revised side  10 ± 1 14 ± 2 
Contralateral side 10 ± 1 14 ± 3 
Cuff PTT 
(kPa) 
Revised side  25 ± 3 41 ± 4 
Contralateral side 28 ± 3 39 ± 4 
 
PPTs and Cuff PPTs were significantly lower in group P compared to 
group NP. In both groups, PTTs obtained from the proximal chamber 
were significantly higher compared to the distal chamber and both 
chambers. 
TSP: VAS scores were significantly higher in group P compared group 
NP for stimulation 4 to 10. 
CPM: In group P, PPTs were significantly reduced from baseline; 
whereas in group NP, PPTs increased significantly from baseline. 
 
Amris et al. 
(2014)74 
Patients with chronic 
widespread pain: 
271 female 
- Age: 45.5 ± 9.7 years 
- BMI: 26.9 ± 5.5 kg/m2 
 
n = 271 
CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- lower leg 
- electronic VAS 
Independent: 
Pneumatic cuff inflation pressure 
 
Dependent: 
PDT 
PTT 
Pain thresholds (Mean ± SD): 
 TPC: 0-8 TPC: 9-18 
PDT (kPa) 15.0 ± 8.4 11.7 ± 7.2 
PTT (kPa) 37.1 ± 14.2 30.7 ± 14.6 
 
Henriksen et al. 
(2014)77 
Patients with tibiofemoral OA: 
Exercise therapy group (EG) 
22 female, 3 male 
- Age: 65.0 ± 8.9 years 
- BMI: 28.9 ± 4.1 kg/m2 
Control group (CG) 
17 female, 6 male 
- Age: 62.3 ± 7.1 years 
- BMI: 28.2 ± 4.6 kg/m2 
 
n = 48 
 
CPA: 
- double-chamber tourniquet cuff 
- affected lower leg, at the bulky part of m. gastrocnemius 
- inflation rate: 1 kPa/s 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
- 3 repetitions 
Assessment of TSP: 
- tonic 6-minute stimulation at 125 % PPT 
- the area under the time-VAS curve was calculated 
Independent: 
Pneumatic cuff inflation pressure 
 
Dependent: 
PPT 
TSP 
Pain thresholds (Mean ± SD): 
 EG CG 
PPT (kPa) 18.2 ± 6.1 19.1 ± 6.8 
TSP (mm × s) 8,887 ± 4,340 6,768 ± 4,388 
 
12-week therapeutic program reduced patients' sensitivity to painful 
stimuli and TSP upon sustained noxious pressure stimulation. 
 
Vladimirova et 
al. (2015)50 
Patients with RA: 
38 female 
- Age: median 56 years, range 
46-69 years 
Healthy controls: 
38 female 
- Age: median 39 years, range 
32-44 years 
 
n = 76 
 
CPA: 
- tourniquet cuff (length 61 cm) 
- dominant lower leg, widest part 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(PDT: VAS > 0 cm) 
- 3 repetitions 
Assessment of TSP: 
- tonic 10-minute of stimulation with (PDT+PTT)/2 intensity 
- TS-index was calculated 
 
Independent: 
Pneumatic cuff inflation pressure 
 
Dependent: 
PDT 
PTT 
TS-index 
Pain thresholds (Mean ± SEM): 
 Patients Controls 
PDT (kPa) 16.4 ± 1.2 24.9 ± 2.0 
PTT (kPa) 40.5 ± 2.5 55.9 ± 3.1 
 
PDT and PTT in patients were significantly lower compared with the 
healthy controls. 
TSP: TS-index in patients was significantly higher compared with the 
healthy controls. 
RA patients suffer from nonarticular pain hypersensitivity and 
facilitated temporal summation, indicating central pain sensitisation. 
 
 
  
Reference Participants Experimental Procedure Variables Findings 
Vaegter et al. 
(2016)80 
Patients with chronic 
musculoskeletal pain (lower 
back, neck, shoulder or elbow): 
Low pain sensitivity (LPS): 
21 female, 9 male 
- Age: 47.3 ± 12.3 years 
- BMI: 25.5 (18.2-42.7) kg/m2  
High pain sensitivity (HPS): 
21 female, 10 male 
- Age: 43.5 ± 9.9 years 
- BMI: 25.9 (17.7-47.6) kg/m2 
 
n = 61 
A) Single-point pressure algometry (hand-held): 
- 1 cm2 probe 
- 4 test sites: 
A1) dominant m. quadriceps femoris (20 cm proximal to the base 
of patella) 
A2) nondominant m. quadriceps femoris (20 cm proximal to the 
base of patella) 
A3) dominant m. biceps brachii (10 cm proximal to the cubital 
fossa) 
A4) nondominant upper m. trapezius 
- 2 repetitions 
- used for subgrouping of patients 
 
B) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- nondominant lower leg, 5 cm distal to the tibial tuberosity 
- inflation rate: 1 kPa/s; maximum pressure limit: 80 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(cPPT: VAS = 1 cm) 
Assessment of TSP: 
- 10 repeated stimulations: 2 s of cPTT intensity, 1 s of 5 kPa 
- 3 mean values calculated: 
VAS I (stimulation 1-4), VAS II (stimulation 5-7) and VAS III 
(stimulation 8-10) 
 
C) Cold pressor test 
D) Exercise-induced hypoalgesia 
E) Maximal voluntary contraction of the dominant m. quadriceps 
femoris 
Independent: 
Probe pressure 
Pneumatic cuff inflation pressure 
 
Dependent: 
PPT 
cPPT 
cPTT 
VAScPTT 
TSP 
Baseline pain thresholds (Mean ± SD): 
 
A) Single-point pressure algometry: 
 LPS HPS 
A1) PPT (kPa) 538 ± 390 
A2) PPT (kPa) 574 ± 390 
A3) PPT (kPa) 321 ± 247 
A4) PPT (kPa) 366 ± 274 
Widespread PPT (kPa) 612.9 ± 343.9 292.2 ± 171.8 
 
B) CPA: 
 LPS HPS 
cPPT (kPa) 28.9 ± 14.0 17.8 ± 7.7 
cPTT (kPa) 57.6 ± 17.0 46.3 ± 18.2 
VAScPTT (cm) 7.7 (1.16-9.99) 8.7 (0.83-9.99) 
VAS I (cm) 2.2 ± 1.5 3.1 ± 2.0 
VAS II (cm) 3.1 ± 1.7 4.5 ± 2.2 
VAS III (cm) 3.6 ± 2.1 5.4 ± 2.3 
 
cPPT and cPTT were significantly lower in HPS compared to LPS. 
TSP: VAS III was significantly higher than VAS II, and VAS II was 
significantly higher than VAS I. VASI-III were significantly higher in HPS 
compared to LPS. TSP was more pronounced in HSP and it was further 
facilitated after aerobic exercise, but not after isometric exercises. 
cPTT and Widespread PPT were increased in response to the cold 
pressor test and exercises in both groups. 
 
Soriano-
Maldonado et al. 
(2016)22 
Patients with tibiofemoral OA: 
61 female, 39 male 
- Age: 63.4 ± 9.3 years 
- BMI: 28.9 ± 3.6 kg/m2 
 
n = 100 
CPA: 
- double-chamber tourniquet cuff 
- affected lower leg at the bulky part of the gastrocnemius muscle 
- inflation rate: 1 kPa/s 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
- 3 repetitions 
Assessment of TSP: 
- tonic stimulation at 125 % PPT, 6 minutes 
- calculation of the area under the time-VAS curve  
 
Independent: 
Pneumatic cuff inflation pressure 
 
Dependent: 
PPT 
TSP 
 
Baseline pain thresholds (Mean ± SD): 
PPT (kPa) 18.5 ± 6.4 
TSP (mm × s) 14,423 ± 8,024 
 
 
  
Reference Participants Experimental Procedure Variables Findings 
Rathleff (2016)72 Patients with patellofemoral 
pain: 
20 female 
- Age: median 20.0 years, range 
19.0-21.0 years 
- Weight: median 63.8 kg, range 
8.3 kg 
- Height: median 170 cm, range 5 
cm 
Pain-free controls: 
20 female 
- Age: median 20.5 years, range 
20.0-21.0 years 
- Weight: median 61.7 kg, range 
7.4 kg 
- Height: median 169 cm, range 5 
cm 
 
n = 40 
A) Single-point pressure algometry (hand-held): 
- 1 cm2 probe 
- test sites: 
A1) knee: center of the patella 
A2) m. tibialis anterior, 5 cm distal to the tibial tuberosity 
A3) elbow: lateral epicondyle of the humerus 
- 2 repetitions 
- reclining position 
 
B) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- affected lower leg, 5 cm distal to the tibial tuberosity 
- inflation rate: 1 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(PDT: VAS = 1 cm) 
Assessment: 
TSP: 
- 10 repeated stimulations: 1 s of PTT intensity, 2 s of 5 kPa 
CPM: 
- conditioning stimulus: inflation of 7.5 cm wide cuff to constant 
pressure 60 kPa at left arm 
- test stimulus: PDT and PTT on contralateral lower leg 
 
Independent: 
Probe pressure 
Pneumatic cuff inflation pressure 
 
Dependent: 
PPT 
PDT 
PTT 
TSP 
CPM 
Pain thresholds, as established from the provided charts (Mean ± SEM): 
 Patients Controls 
PPT (kPa) A1 309 ± 30 400 ± 36 
A2 376 ± 33 455 ± 30 
A3 285 ± 23 317 ± 28 
PDT (kPa) 31 ± 8 37 ± 10 
PTT (kPa) 75 ± 9 84 ± 9 
 
A significant difference between PPTs in patients and controls was 
found. There were no significant differences in PDT or PTT between 
patients and controls. 
TSP: No significant differences were found between patients and 
controls in the increase in VAS. 
CPM: Patients had a 78 % lower CPM response in PDT and 20 % lower 
CPM response in PTT compared to controls. 
 
Vaegter and 
Graven-Nielsen 
(2016)82 
Patients with chronic pain: 
Group 1: 
facilitated TSP, impaired CPM 
63 female, 22 male 
Group 2: 
normal TSP, impaired CPM 
101 female, 47 male 
Group 3: 
facilitated TSP, normal CPM 
30 female, 15 male 
Group 4: 
normal TSP, normal CPM 
69 female, 53 male 
Age: 48.0 ± 12.5 years 
 
n = 400 
 
A) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- left lower leg, 5 cm distal to the tibial tuberosity 
- inflation rate: 1 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(cPPT = 1 cm VAS) 
- 2 repetitions 
Assessment: 
TSP: 
- 10 repeated stimulations: 1 s of cPTT intensity, 1 s of 5 kPa 
- 3 mean values calculated: 
VAS I (stimulation 1-4), VAS II (stimulation 5-7) and VAS III 
(stimulation 8-10) 
CPM: 
- conditioning stimulus: inflation of 7.5 cm wide cuff to constant 
pressure 30 kPa at right lower leg, 8 cm distal to the tibial 
tuberosity 
- test stimulus: CPA on left lower leg 
- single-point algometry 
 
B) Thermal pain sensitivity 
 
Independent: 
Pneumatic cuff inflation pressure 
 
Dependent: 
cPPT 
cPTT 
VAScPTT 
TSP 
CPM 
Pain thresholds (Mean ± SD): 
 Female Male 
G1 G2 G3 G4 G1 G2 G3 G4 
cPPT 
(kPa) 
17.6 ± 
7.8 
17.0 ± 
7.9 
18.9 ± 
8.1 
17.5 ± 
6.9 
25.0 ± 
9.5 
26.9 ± 
12.0 
23.5 ± 
9.8 
24.2 ± 
9.8 
cPTT 
(kPa) 
34.1 ± 
14.5 
35.5 ± 
14.5 
42.5 ± 
18.1 
45.4 ± 
18.0 
49.3 ± 
21.0 
52.0 ± 
18.6 
53.9 ± 
21.2 
58.8 ± 
21.3 
VAS 
cPTT 
(cm) 
8.7 ± 
2.0 
8.7 ± 
1.9 
8.5 ± 
2.2 
9.2 ± 
1.6 
7.8 ± 
2.3 
9.3 ± 
1.2 
8.8 ± 
1.9 
9.0 ± 
1.7 
 
CPM: 
 Before conditioning After conditioning 
cPPT (kPa) 20.0 ± 9.4 23.0 ± 14.3 
cPTT (kPa) 44.1 ± 19.4 44.1 ± 21.8 
 
cPPT and cPTT were significantly increased during conditioning cuff 
stimulation. 
Group 1 had a significantly higher proportion of patients with 
widespread pain and group 4 had a significantly higher proportion of 
patients with localized neck pain than the other groups. Group 1 had 
more pain areas than the other 3 groups. 
Pain modulatory phenotypes are important determinants of pain status 
in patients with chronic pain and seem to be heterogeneous across 
different pain diagnosis. 
 
Reference Participants Experimental Procedure Variables Findings 
Petersen et al. 
(2016)76 
Patients with knee OA 
scheduled for TKA: 
Group A: 
facilitated TSP, impaired CPM 
n = 16, 73.3 % female 
- Age: 73.2 ± 2.1 years 
- BMI: 28.5 ± 1.2 kg/m2 
Group B: 
facilitated TSP, normal CPM 
n = 15, 57.1 % female 
- Age: 69.6 ± 2.2 years 
- BMI: 32.2 ± 1.7 kg/m2 
Group C: 
normal TSP, impaired CPM 
n = 44, 70.7 % female 
- Age: 66.8 ± 1.7 years 
- BMI: 30.4 ± 0.8 kg/m2 
Group D: 
normal TSP, normal CPM 
n = 28, 51.9 % female 
- Age: 67.0 ± 1.7 years 
- BMI: 28.6 ± 1.1 kg/m2 
 
n = 103 
 
A) Single-point pressure algometry (hand-held): 
- 1 cm2 probe 
- test sites: 
- knee: peripatellar region (7 sites) 
- TA: m. tibialis anterior (2 sites) 
- arm: m. extensor carpi radialis longus 
- 2 repetitions 
 
B) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- lower leg at the level of the head of m. gastrocnemius 
- inflation rate: 1 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(PDT = > 2 cm VAS) 
- 3 repetitions 
Assessment: 
TSP: 
- 10 repeated stimulations: 1 s of (PDT+PTT)/2 intensity, 1 s of 1 kPa 
- 2 mean values calculated: 
VAS I (stimulation 1-7), VAS II (stimulation 8-10) 
CPM: 
- conditioning stimulus: 
inflation of 7.5 cm wide cuff to constant pressure 60 kPa (5 cm VAS) 
- test stimulus: 
PPT on ipsilateral lower leg 
single-point algometry 
 
Independent: 
Probe pressure 
Pneumatic cuff inflation pressure 
 
Dependent: 
PPT 
PDT 
PTT 
TSP 
CPM 
Preoperative pain thresholds, as established from the provided charts 
(Mean ± SEM): 
 
A) Single-point pressure algometry 
 PPT (kPa) 
Group Knee TA Arm 
A 143 ± 52 178 ± 76 135 ± 78 
B 227 ± 63 199 ± 59 123 ± 45 
C 214 ± 39 234 ± 47 152 ± 36 
D 258 ± 42 268 ± 49 124 ± 54 
 
B) CPA 
Group PDT (kPa) PTT (kPa) 
A 11 ± 1 23 ± 2 
B 10 ± 1 27 ± 2 
C 15 ± 1 30 ± 3 
D 18 ± 2 35 ± 2 
 
No significant difference in PPTs was found between the groups. Group 
D showed significantly higher PDT values compared with groups A and 
B and higher PTT values compared with group A. 
TSP: Significantly less TSP: B, C, D compared with A; C, D comp. with B. 
CPM: Groups A and C showed significantly impaired CPM compared 
with groups B and D. No significant difference was found between the 
groups with facilitated and normal TSP. 
 
Petersen et al. 
(2017)73 
Patients with knee OA 
scheduled for TKA: 
< 65 years: 33 female, 16 male 
- Age: 57.3 years (SEM 0.8) 
- BMI: 32.9 kg/m2 (SEM 1.0) 
> 65 years: 51 female, 33 male 
- Age: 73.6 years (SEM 0.6) 
- BMI: 28.6 kg/m2 (SEM 0.4) 
Healthy controls: 
< 65 years: 15 female, 11 male 
- Age: 58.5 years (SEM 0.7) 
- BMI: 27.0 kg/m2 (SEM 1.1) 
> 65 years: 10 female, 14 male 
- Age: 70.4 years (SEM 0.8) 
- BMI: 25.8 kg/m2 (SEM 1.1) 
 
n = 185 
 
A) Single-point pressure algometry (hand-held): 
- 1 cm2 probe 
- lower limb: m. tibialis anterior 
 
B) Computerized cuff pressure algometry (CPA): 
B1) single-chamber tourniquet cuff (width 7 cm) 
B2) double-chamber tourniquet cuff (width 13 cm) 
- lower leg, at the level of the heads of m. gastrocnemius 
- inflation rate: 1 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
- MPDT = VAS>2 cm 
- 3 repetitions 
- supine position 
Independent: 
Probe pressure 
Pneumatic cuff inflation pressure 
 
Dependent: 
PPT 
MPDT 
PTT 
Pain thresholds, as established from the provided charts (Mean ± SEM): 
 
B1) Single-chamber cuff 
 Patients Controls 
< 65 years > 65 years < 65 years > 65 years 
MPDT (kPa) 15 ± 2 13 ± 1 26 ± 2 20 ± 2 
PTT (kPa) 29 ± 2 29 ± 1 48 ± 2 43 ± 4 
 
B2) Double-chamber cuff 
 Patients Controls 
< 65 years > 65 years < 65 years > 65 years 
MPDT (kPa) 12 ± 2 13 ± 1 19 ± 1 16 ± 2 
PTT (kPa) 28 ± 2 26 ± 1 35 ± 2 34 ± 2 
 
Patients showed lower PPTs compared with controls. 
TSP in patients was significantly facilitated compared with controls. 
CPM: Unsignificant impairment in patients compared with controls. 
Age correlated significantly with pain thresholds but not TSP or CPM. 
 
 
Reference Participants Experimental Procedure Variables Findings 
Vaegter et al. 
(2017b)81 
Patients with chronic back pain: 
Cervical pain (CP): 
12 female, 5 male 
- Age: 42.8 ± 9.4 years 
- BMI: 28.8 ± 6.9 kg/m2 
Cervical radiating pain (CRP) 
10 female, 7 male 
- Age: 45.9 ± 10.1 years 
- BMI: 27.5 ± 6.1 kg/m2 
Low back pain (BP) 
9 female, 9 male 
- Age: 49.7 ± 14.8 years 
- BMI: 25.8 ± 3.2 kg/m2 
Low back radiating pain (BRP) 
12 female, 6 male 
- Age: 53.3 ± 14.5 years 
- BMI: 26.2 ± 5.0 kg/m2 
 
n = 70 
 
CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- left lower leg, 5 cm distal to the tibial tuberosity 
- inflation rate: 1 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(cPPT: VAS > 2 cm) 
- 2 repetitions 
- seated position 
Assessment: 
TSP: 
- 10 repeated stimulations: 1 s of cPTT intensity, 1 s of 5 kPa 
- 3 mean values calculated: 
VAS I (stimulation 1-4), VAS II (stimulation 5-7) and VAS III 
(stimulation 8-10) 
CPM: 
- conditioning stimulus: 
inflation of 7.5 cm wide cuff to constant pressure 30 kPa 
right lower leg, 8 cm distal to the tibial tuberosity 
- test stimulus: 
CPA on left lower leg 
 
B) Thermal pain sensitivity 
 
Independent: 
Pneumatic cuff inflation pressure 
 
Dependent: 
cPPT 
cPTT 
VAScPTT 
TSP 
CPM 
Pain thresholds (Mean ± SD): 
 CP CRP BP BRP Total 
cPPT (kPa) 26.1 ± 
11.7 
22.5 ± 1.2 21.9 ± 9.7 24.2 ± 1.3 23.6 ± 
1.4 
cPTT (kPa) 58.7 ± 
19.5 
40.2 ± 
16.2 
48.2 ± 
19.1 
50.1 ± 
17.0 
49.3 ± 
18.8 
VAScPTT 
(cm) 
8.7 ± 1.8 7.8 ± 1.9 8.3 ± 2.2 8.5 ± 2.0 8.3 ± 1.9 
 
Patients with BP displayed lower pressure pain thresholds than patients 
with CP. 
TSP: Patients with radiating pain had higher TSP compared with 
patients with localized pain. 
CPM: Patients with CRP had a reduced CPM response compared with 
patients with CP. 
Vaegter et al. 
(2017a)75 
Patients with knee OA 
scheduled for unilateral TKA: 
7 female, 7 male 
- Age: 66.3 ± 5.9 years 
- BMI: 28.3 ± 3.1 kg/m2 
 
n = 14 
A) Single-point pressure algometry (hand-held): 
- 1 cm2 probe 
- 4 test sites: 
A1) affected m. quadriceps femoris  
A2) nonaffected m. quadriceps femoris 
(both 20 cm proximal to the base of patella) 
A3) m. biceps brachii (10 cm proximal to the cubital fossa) 
A4) nondominant upper m. trapezius 
- 2 repetitions 
 
B) CPA: 
- double-chamber tourniquet cuff (width 13 cm) 
- affected lower leg, 5 cm distal to the tibial tuberosity 
- inflation rate: 1 kPa/s; maximum pressure limit: 100 kPa 
- electronic VAS (0 - no pain, 10 - maximal pain), sampling at 10 Hz 
(cPPT: VAS = 1 cm) 
 
C) Cold pressor test 
D) Exercise-induced hypoalgesia 
E) Maximal voluntary contraction of m. quadriceps femoris 
 
Independent: 
Probe pressure 
Pneumatic cuff inflation pressure 
 
Dependent: 
PPT 
cPPT 
cPTT 
Pain thresholds (Mean ± SD): 
 Baseline 6 months after 
TKA 
PPT (kPa) A1 500.1 ± 214.9 574.8 ± 248.7 
A2 577.0 ± 315.2 549.2 ± 238.4 
A3 288.9 ± 121.5 288.6 ± 130.0 
A4 389.0 ± 134.3 397.4 ± 163.2 
cPPT (kPa) 19.4 ± 13.7 24.4 ± 12.9 
cPTT (kPa) 49.9 ± 20.8 46.3 ± 21.7 
 
 
Table 1: Summary of studies reviewed. Abbreviations: Circ. – Lower leg circumference; CPM - Conditioned Pain Modulation; cPPT - Cuff Pressure-Pain Threshold; cPTT - Cuff 
Pressure-Pain Tolerance; Cuff PPT - Cuff Pressure-Pain Threshold; Cuff PTT - Cuff Pressure-Pain Tolerance; MPDT - Mild Pain Detection Threshold, OA - Osteoarthritis; PDT - 
Pain Detection Threshold; PPT - Pressure-Pain Threshold; PTI - Pain Tolerance Intensity; PTT - Pain Tolerance Threshold; RA - Rheumatoid Arthritis; SSP - Spatial Summation of 
Pain; TS-index - Temporal Summation Index; TSP - Temporal Summation of Pain; VAScPTT - Score on the Visual Analogue Scale at cPTT; VAS at PTT - Score on the Visual 
Analogue Scale at PTT.
 Reference n CPA Single-point algometry 
  PDT (kPa) PTT (kPa) PPT (kPa) 
  Patients Controls Patients Controls Patients Controls 
Jespersen et al. (2007)15 64 15 20 34 44 - - 
Amris et al. (2010)19 81 9 - 31 - - - 
Lemming et al. (2012)59 35 18 - 23 23 - 29 39 - 52 50 - 62 - - 
Graven-Nielsen et al. (2012)49 69 25 - 34 35 - 42 - - - - 
Jespersen et al. (2013)21 60 21 - 23 25 - 36 51 - 62 56 - 80 - - 
Skou et al. (2013)79 17 9 - - - 419 - 469 - 
Skou et al. (2013)78 40 10 - 19 - 25 - 53 - - - 
Amris et al. (2014)74 271 12 - 15 - 31 - 37 - - - 
Henriksen et al. (2014)77 48 18 19 - - - - 
Vladimirova et al. (2015)50 76 16 25 41 56 - - 
Vaegter et al. (2016)80 61 18 - 29 - 46 - 58 - - - 
Soriano-Maldonado et al. 
(2016)22 
100 19 - - - - - 
Rathleff (2016)72 40 31 37 75 84 285 - 376 317 - 455 
Vaegter and Graven-Nielsen 
(2016)82 
400 17 - 27 - 34 - 59 - - - 
Petersen et al. (2016)76 103 10 - 18 - 23 - 35 - - - 
Petersen et al. (2017)73 185 12 - 15 16 - 26 26 - 29 34 - 48 - - 
Vaegter et al. (2017b)81 70 22 - 26 - 40 - 59 - - - 
Vaegter et al. (2017a)75 14 19 - 24 - 46 - 50 - 289 - 577 - 
 
Table 2: Summary of PDT, PTT and PPT data across the studies. The minimal and maximal values for 
patients are indicated in bold. PDT - Pain Detection Threshold, PPT - Pressure-Pain Threshold, PTT - 
Pain Tolerance Threshold. 
 
4. Discussion 
 
4.1. Participants 
The literature search for this review specifically targeted studies of CPA on patients with chronic pain. 
The results of our search indicate that most of the research focused on middle- or older-age adults 
with chronic musculoskeletal pain or osteoarthritis. As these conditions also hamper mobility, we 
believe these groups are a reasonable reflection of potential candidates for assistive soft exoskeletons 
for mobility. 
 
4.2. Pressure-induced pain thresholds in patients with chronic pain 
The studies reviewed reveal a common pattern in pressure-pain sensitivity in patients with chronic 
pain, indicating hypersensitivity to mechanical stimulation.15  
When CPA was performed using both chambers of a double-chambered cuff at the lower leg, the 
mean PDT levels were under 20 kPa (median 17.9 kPa) for patients in 19 of 28 cases, and the mean 
PTT levels under 40 kPa (median 38 kPa) in 14 of 24 cases. Compared to the PPTs of healthy 
participants, that we found in our previous review (PDTs typically 20-27 kPa, PTTs typically over 40 
kPa),13 these levels are notably lower, which needs to be considered by exoskeleton developers. On 
the other hand, higher pain sensitivity was found in the lower limb compared to the upper limb both 
in patients and healthy controls, and the rating of unbearable pain intensity on the VAS was similar 
between patients and healthy controls. 
 
 
Generalized hyperalgesia was found in patients with widespread pain as well as patients with localized 
primary pain, indicating changes in central pain modulating mechanisms. Although these changes 
show heterogeneity across different diagnoses, in general facilitation of pronociceptive mechanisms 
(TSP) and impairment of antinociceptive mechanisms (CPM) was found, indicating central 
sensitisation. Because of central sensitisation, pain thresholds at all sites of the body are lower than 
normal, which needs to be considered when components of the exoskeleton interface with segments 
other than the lower limbs. However, no significant differences in SSP were found between healthy 
controls and patients, and the central pain-modulating mechanisms were not significantly influenced 
by increasing age in the studies reviewed. 
 
 
4.3. Differences across the reviewed studies 
4.3.1 Pressure-induced pain thresholds 
The reviewed studies report over threefold differences in patients’ PDTs19,72 and PTTs,72,76 and over 
twofold differences in healthy controls’ PDTs72,73 and PTTs.72,73 As the prominent outliers occur 
together in certain studies,49,72,73,80 and the thresholds differ largely among the healthy control groups 
as well, we expect that the differences might be mostly due to the assessment methods and use of 
subjective rating scales. 
 
4.3.2. Assessment methods 
The assessment of TSP differed among the studies according to the number and duration of the 
mechanical stimuli and the magnitude of compression. The tonic stimuli lasted 6-10 minutes and their 
magnitude was set to either 25 kPa, 125 % of PDT or the mean between the assessed PDT and PTT. 
The 6-minute tonic stimulation was therefore performed at 22.8-23.9 kPa of compression, and the 10-
minute tonic stimulation was performed at 28.5-63.7 kPa of compression. The intermittent stimulation 
consisted of 10 consequent compressions of different magnitudes and durations. Stimulations that 
lasted 1 second were performed at either the mean value of PDT and PTT (16.5-58.8 kPa), or at PTT 
(40.2-75 kPa); the 2-second stimulation was performed at PTT (46.3-57.6 kPa). The inter-stimulus 
intervals ranged from 1 to 2 seconds. As sustained constant pressure was previously shown to result in 
adaptation to pain in healthy adults, whereas oscillating pressure caused an increase in pain intensity 
with time,16,55,83 the comparison of these results may not be adequate. 
 
4.3.3. Terminology and definition of pressure-induced pain thresholds 
As discussed in our previous systematic review,13 the terminology and definitions of measured 
parameters in CPA need to be standardized. In the articles reviewed, the pressure magnitude at which 
pain occurs was termed Cuff Pressure-Pain Threshold (cPPT, Cuff PPT), Mild Pain Detection Threshold 
(MPDT), or Pain Detection Threshold (PDT); and the pressure magnitude that causes unbearable pain 
was termed Cuff Pressure-Pain Tolerance (cPTT, Cuff PTT), or Pain Tolerance Threshold (PTT). 
Moreover, PDT was defined as the pressure magnitude when the rating on VAS either exceeded 0 cm, 
was equal to 1 cm, or exceeded 2 cm, and 5 studies did not explicitly define the rating on VAS at PDT. 
To enable comparison of the results across studies, we propose that experimental procedures and 
scientific reports follow a well-defined standard. 
 
4.4 CPA-derived guidance for the development of soft exoskeleton circumferential pressure 
We note that there have been several different approaches employed so far in the study of external 
loading of the human body during the use of devices that assist with locomotion, ranging from animal 
studies,84,85 computer simulations,14,85-89 artificial tissue testing,90,91 human cadaveric tissue testing92 
and usability testing on humans.2,4 
Computer simulations of exoskeleton interactions and physical experiments performed on artificial or 
cadaveric tissues lack the realism of functional anatomical structures, such as nerves, blood and lymph 
vessels, and homeostatic mechanisms, as in human beings. While efficiently simulating the gross 
biomechanics of human-robot interactions does provide highly valuable design insights, such testing 
approaches have many limitations by way of the complete effect on living tissues. 
 
There are limited published studies on testing of exoskeletons performed on humans in vivo. Many 
focus on the measurement of interface pressures alone2,4 while offering little insight into the effects of 
the external loading/assistance on perception of comfort, and soft tissue viability and physiology. We 
were only able to find one previous study of  perceived pressure ,93 and one where algometry was 
performed in the context of tissue loading by wearable devices.12 In the latter study, pressure 
sensitivity was assessed at 9 anatomical points on the lower limb using single-point algometry where 
large differences were identified, with PDTs ranging from 282-628 kPa. As discussed in our previous 
paper,13 that study emphasized that the limits were not valid for sustained non-punctual external 
loading. 
 
As pain is a good indicator of potential tissue damage caused by overpressure,12 CPA is possibly the 
most relevant method to use to inform soft exoskeleton design. However, it does not provide insight 
into the pre-pain discomfort perception or the influence of cyclical compression during walking. 
Therefore, we propose a modification of this method to better simulate the loading of soft tissues 
during the use of wearable robots that apply intermittent pressure (e.g. to promote movement of 
joints) or tonic pressure (e.g. to inhibit movement of joints) to the lower limbs for longer durations. 
Moreover, wearable devices should not cause pain nor discomfort, therefore we suggest adapting 
algometry to measuring discomfort. Further research is needed to understand whether the described 
physiological mechanisms of pain perception apply to the perception of discomfort as well. Finally, we 
acknowledge that the reported PDTs and PTTs represent cuff-inflation pressures and not the interface 
pressure. Although both have been found to be directly related94 and to not differ significantly when 
using a 6 cm wide cuff,95 the exact relationship between cuff-inflation and interface pressure still 
needs to be established.  
 
4.5 Limitations 
The present review summarizes pain-inducing pressure thresholds achieved by CPA in patients with 
chronic pain. We propose that these results can help inform safe thresholds for circumferential 
compression of the lower limbs in potential wearable robotics users. However, the pressures reported 
are cuff-inflation pressures and not interface pressures, and the exact relationship between the two 
still needs to be further studied. Moreover, CPA studies focus on painful mechanical loading of tissues 
and do not provide insight into the pre-pain discomfort perception which is the point of interest in 
wearable robotics design. Finally, CPA testing is performed in static conditions with the participant in a 
supine position, and with compression of short durations, thus more research is needed to understand 
the development of discomfort during longer durations of cyclical compression in the upright position, 
as applied during the use of soft lower-limb exoskeletons. 
 
5. Conclusions 
For this review, we identified 18 studies where computerized cuff pressure algometry was performed 
on patients with chronic pain. Most of the patients identified were middle- or older-age adults with 
chronic musculoskeletal pain or osteoarthritis. 
 
The patients’ mean levels for PDT at the lower leg were typically under 20 kPa (median 17.9 kPa), and 
the mean PTT levels under 40 kPa (median 38 kPa), which is notably lower than the pressure-induced 
pain thresholds of healthy participants (PDTs typically 20-27 kPa, PTTs typically over 40 kPa).13 
Significantly higher pain sensitivity was found in the lower limb compared to the upper limb, and with 
wider tourniquet cuffs. Furthermore, in patients both sustained constant pressure and oscillating 
pressure caused an increase in pain intensity with time. As patients with chronic pain are potential 
candidates for gait-assistive soft exoskeletons, hypersensitivity to pressure-induced pain needs to be 
considered when designing the physical human-device interface. 
 
The results acquired by cuff pressure algometry give important insight into the relationship between 
external loading and pain in patients with chronic pain. We believe that a modification of this method 
could be used to gain insight into the development of discomfort during longer durations of cyclical 
compression, which may occur when soft robotics are used for wearable assistive device applications.  
 
6. Acknowledgements 
This research was completed as part of the XoSoft project, which has received funding from the  
European Union's Horizon 2020 framework programme for research and innovation under grant 
agreement number 688175. 
 
7. References 
 
1. Asbeck AT, De Rossi SMM, Galiana I, Ding Y, Walsh CJ. Stronger, Smarter, Softer: Next-
Generation Wearable Robots. Robotics &amp; Automation Magazine, IEEE. 2014;21(4):22-33. 
2. De Rossi SMM, Vitiello N, Lenzi T, Ronsse R, Koopman B, Persichetti A, et al. Sensing 
Pressure Distribution on a Lower-Limb Exoskeleton Physical Human-Machine Interface. 
Sensors (Basel, Switzerland). 2010;11(1):207-227. 
3. Reenalda J, Jannink M, Nederhand M, Ijzerman M. Clinical Use of Interface Pressure to Predict 
Pressure Ulcer Development: A Systematic Review. Assistive Technology. 2009;21(2):76-85. 
4. Tamez-Duque J, Cobian-Ugalde R, Kilicarslan A, Venkatakrishnan A, Soto R, Contreras-Vidal J. 
Real-Time Strap Pressure Sensor System for Powered Exoskeletons. Sensors. 2015;15(2):4550-
4563. 
5. Sangeorzan BJ, Harrington RM, Wyss CR, Czerniecki JM, Matsen FA. Circulatory and 
mechanical response of skin to loading. Journal of Orthopaedic Research. 1989;7(3):425-431. 
6. Linder-Ganz E, Gefen A. Stress analyses coupled with damage laws to determine 
biomechanical risk factors for deep tissue injury during sitting.(Author abstract)(Report). 
Journal of Biomechanical Engineering. 2009;131(1):11003. 
7. Oomens CWJ, Loerakker S, Bader DL. The importance of internal strain as opposed to interface 
pressure in the prevention of pressure related deep tissue injury. Journal of Tissue Viability. 
2010;19(2):35-42. 
8. Agam L, Gefen A. Pressure ulcers and deep tissue injury: a bioengineering perspective. Journal 
of Wound Care. 2007;16(8):336-342. 
9. Bouten CV, Oomens CW, Baaijens FP, Bader DL. The etiology of pressure ulcers: skin deep or 
muscle bound? Archives Of Physical Medicine And Rehabilitation. 2003;84(4):616-619. 
10. Mak AFT, Zhang M, Boone D. State-of-the-art research in lower-limb prosthetic biomechanics-
socket interface: A review. In. J. Rehabil. Res. Dev. Vol 382001:161-173. 
11. Manafi-Khanian B, Arendt-Nielsen L, Graven-Nielsen T. An MRI-based leg model used to 
simulate biomechanical phenomena during cuff algometry: a finite element study. Med Biol 
Eng Comput. 2016;54(2):315-324. 
12. Pons JL. Wearable robots: Biomechatronic exoskeletons. In. Hoboken, N.J: Wiley; 2008:154-
156. 
13. Kermavnar T, Power V, de Eyto A, O’Sullivan L. Computerized Cuff Pressure Algometry as 
Guidance for Circumferential Tissue Compression for Wearable Soft Robotic Applications: A 
Systematic Review. In: Soft Robotics; 2017:Article in Press. 
14. Manafi‐Khanian B, Arendt‐Nielsen L, Frøkjær JB, Graven‐Nielsen T. Deformation and pressure 
propagation in deep somatic tissue during painful cuff algometry. European Journal of Pain. 
2015;19(10):1456-1466. 
15. Jespersen A, Dreyer L, Kendall S, Graven-Nielsen T, Arendt-Nielsen L, Bliddal H, 
Danneskiold-Samsoe B. Computerized cuff pressure algometry: A new method to assess 
deep-tissue hypersensitivity in fibromyalgia. Pain. 2007;131(1):57-62. 
16. Graven-Nielsen T, Vaegter HB, Finocchietti S, Handberg G, Arendt-Nielsen L. Assessment of 
musculoskeletal pain sensitivity and temporal summation by cuff pressure algometry: a 
reliability study. Pain. 2015;156(11):2193. 
17. Bartels EM, Danneskiold-Samsøe B. Pain assessment in fibromyalgia. In: Novel Insights into the 
Pathophysiology and Treatment of Fibromyalgia. London: Future Medicine Ltd; 2014:38-44. 
18. Izumi M, Petersen KK, Arendt-Nielsen L, Graven-Nielsen T. Pain referral and regional deep 
tissue hyperalgesia in experimental human hip pain models. Pain. 2014;155(4):792-800. 
19. Amris K, Jespersen A, Bliddal H. Self-reported somatosensory symptoms of neuropathic pain in 
fibromyalgia and chronic widespread pain correlate with tender point count and pressure-pain 
thresholds. Pain. 2010;151(3):664-669. 
20. Polianskis R, Graven-Nielsen T, Arendt-Nielsen L. Pressure-pain function in desensitized and 
hypersensitized muscle and skin assessed by cuff algometry. Journal of Pain. 2002;3(1):28-37. 
21. Jespersen A, Amris K, Graven‐Nielsen T, Arendt‐Nielsen L, Bartels EM, Torp‐Pedersen S, et 
al. Assessment of Pressure‐Pain Thresholds and Central Sensitization of Pain in Lateral 
Epicondylalgia. Pain Medicine. 2013;14(2):297-304. 
22. Soriano-Maldonado A, Klokker L, Bartholdy C, Bandak E, Ellegaard K, Bliddal H, Henriksen 
M. Intra-articular corticosteroids in addition to exercise for reducing pain sensitivity in knee 
osteoarthritis: Exploratory outcome from a randomized controlled trial. PLoS ONE. 2016;11(2). 
23. Christensen AW, Rifbjerg-Madsen S, Christensen R, Amris K, Taylor PC, Locht H, et al. 
Temporal summation of pain and ultrasound Doppler activity as predictors of treatment 
response in patients with rheumatoid arthritis: protocol for the Frederiksberg hospitals 
Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study. BMJ 
Open. 2014;4(1). 
24. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes 
and definitions of pain terms. Second edition. ed. Seattle: IASP Press; 1994. 
25. Treede R-D. Entstehung der Schmerzchronifizierung. In: Baron R, Koppert W, Strumpf M, 
Willweber-Strumpf A, eds. Praktische Schmerzmedizin: Interdisziplinäre Diagnostik – 
Multimodale Therapie. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013:3-13. 
26. Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The Prevalence of Chronic Pain in 
United States Adults: Results of an Internet-Based Survey. Journal of Pain. 2010;11(11):1230-
1239. 
27. Wade KF, Marshall A, Vanhoutte B, Wu FCW, Neill TW, Lee DM. Does pain predict frailty in 
older men and women? findings from the english longitudinal study of ageing (ELSA). Journals 
of Gerontology - Series A Biological Sciences and Medical Sciences. 2016;72(3):403-409. 
28. Wade KF, Lee DM, McBeth J, Ravindrarajah R, Gielen E, Pye SR, et al. Chronic widespread 
pain is associated with worsening frailty in European men. Age and Ageing. 2016;45(2):268-
274. 
29. Wade K, Lee D, Pendleton N, Vanderschueren D, Bartfai G, Casanueva F, et al. Does chronic 
pain increase the risk of developing frailty? Results from the european male ageing study. Age 
And Ageing. 2015;44:18-18. 
30. Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of 
community burden and current use of primary health care. Ann Rheum Dis. 2001;60(2):91. 
31. Christmas C, Crespo CJ, Franckowiak SC, Bathon JM, Bartlett SJ, Andersen RE. How common is 
hip pain among older adults? Results from the third National Health and Nutrition 
Examination Survey. (Original Research). Journal of Family Practice. 2002;51(4):345. 
32. Morone NE, Karp JF, Lynch CS, Bost JE, El Khoudary SR, Weiner DK. Impact of Chronic 
Musculoskeletal Pathology on Older Adults: A Study of Differences between Knee OA and Low 
Back Pain. Pain Medicine. 2009;10(4):693-701. 
33. Weaver GD, Kuo YF, Raji MA, Al Snih S, Ray L, Torres E, Ottenbacher KJ. Pain and Disability 
in Older Mexican‐American Adults. Journal of the American Geriatrics Society. 2009;57(6):992-
999. 
34. Ling SM, Fried LP, Garrett ES, Fan M-Y, Rantanen T, Bathon JM. Knee osteoarthritis 
compromises early mobility function: The Women's Health and Aging Study II. The Journal of 
Rheumatology. 2003;30(1):114-120. 
35. Arendt-Nielsen L, Graven-Nielsen T, Fernández-de-las-Peñas C. Basic aspects of 
musculoskeletal pain: From acute to chronic pain. Journal of Manual and Manipulative 
Therapy. 2011;19(4):186-193. 
36. Finnerup NB, Norrbrink C, Trok K, Piehl F, Johannesen IL, Sørensen JC, et al. Phenotypes 
and Predictors of Pain Following Traumatic Spinal Cord Injury: A Prospective Study. Journal of 
Pain. 2014;15(1):40-48. 
37. Siddall PJ, McClelland JM, Rutkowski SB, Cousins MJ. A longitudinal study of the prevalence 
and characteristics of pain in the first 5 years following spinal cord injury. Pain. 
2003;103(3):249-257. 
38. Störmer S, Gerner HJ, Grüninger W, Metzmacher K, Föllinger S, Wienke CH, et al. Chronic 
pain/dysaesthesiae in spinal cord injury patients: results of a multicentre study. Spinal Cord. 
1997;35(7):446. 
39. Werhagen L, Budh CN, Hultling C, Molander C. Neuropathic pain after traumatic spinal cord 
injury – relations to gender, spinal level, completeness, and age at the time of injury. Spinal 
Cord. 2004;42(12):665. 
40. Aranda‐Villalobos P, Fernández‐De‐Las‐Peñas C, Navarro‐Espigares JL, Hernández‐Torres E, 
Villalobos M, Arendt‐Nielsen L. Normalization of Widespread Pressure Pain Hypersensitivity 
After Total Hip Replacement in Patients With Hip Osteoarthritis Is Associated With Clinical and 
Functional Improvements. Arthritis &amp; Rheumatism. 2013;65(5):1262-1270. 
41. Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, Madeleine P, Simonsen OH, Graven-
Nielsen T. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149(3):573-
581. 
42. Graven-Nielsen T, Arendt-Nielsen L. Assessment of mechanisms in localized and widespread 
musculoskeletal pain. Nature Reviews Rheumatology. 2010;6(10):599-606. 
43. Bingel U, Herken W, Teutsch S, May A. Habituation to painful stimulation involves the 
antinociceptive system - a 1-year follow-up of 10 participants. In. Vol 1402008:393-394. 
44. Schaible HG. Peripheral and Central Mechanisms of Pain Generation. In: Stein C, ed. Analgesia. 
Berlin: Springer Berlin Heidelberg; 2007:3-28. 
45. Latremoliere A, Woolf CJ. Central Sensitization: A Generator of Pain Hypersensitivity by 
Central Neural Plasticity. Journal of Pain. 2009;10(9):895-926. 
46. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal 
summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain. 
2001;91(1):165-175. 
47. Price DD, Staud R, Robinson ME, Mauderli AP, Cannon R, Vierck CJ. Enhanced temporal 
summation of second pain and its central modulation in fibromyalgia patients. Pain. 
2002;99(1):49-59. 
48. Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, Bengtsson M, Sörensen J, Johnson A, 
et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia 
patients. Pain. 2000;85(3):483-491. 
49. Graven‐Nielsen T, Wodehouse T, Langford RM, Arendt‐Nielsen L, Kidd BL. Normalization of 
widespread hyperesthesia and facilitated spatial summation of deep‐tissue pain in knee 
osteoarthritis patients after knee replacement. Arthritis &amp; Rheumatism. 2012;64(9):2907-
2916. 
50. Vladimirova N, Jespersen A, Bartels EM, Christensen AW, Bliddal H, Danneskiold-Samsøe B. 
Pain Sensitisation in Women with Active Rheumatoid Arthritis: A Comparative Cross-Sectional 
Study. Arthritis. 2015;2015. 
51. Defrin R, Ronat A, Ravid A, Peretz C. Spatial summation of pressure pain: effect of body region. 
Pain. 2003;106(3):471-480. 
52. Greenspan JD, Thomadaki M, McGillis SL. Spatial summation of perceived pressure, sharpness 
and mechanically evoked cutaneous pain. Somatosensory &amp; motor research. 
1997;14(2):107. 
53. Graven-Nielsen T, Arendt-Nielsen L. Translational aspects of musculoskeletal pain: From 
animals to patients. In: Arendt-Nielsen L, ed. Fundamentals of Musculoskeletal Pain. Seattle, 
WA: ASP Press; 2008:347–366. 
54. Anderson RJ, Craggs JG, Bialosky JE, Bishop MD, George SZ, Staud R, Robinson ME. 
Temporal summation of second pain: Variability in responses to a fixed protocol. European 
Journal of Pain. 2013;17(1):67-74. 
55. Vaegter HB, Handberg G, Graven‐Nielsen T. Isometric exercises reduce temporal summation 
of pressure pain in humans. European Journal of Pain. 2015;19(7):973-983. 
56. Staud R. The important role of CNS facilitation and inhibition for chronic pain. International 
Journal. 2013;8(6):639-646. 
57. Finocchietti S, Arendt-Nielsen L, Graven-Nielsen T. Tissue characteristics during temporal 
summation of pressure-evoked pain. Experimental Brain Research. 2012;219(2):255-265. 
58. Staud R, Cannon RC, Mauderli AP, Robinson ME, Price DD, Vierck CJ. Temporal summation of 
pain from mechanical stimulation of muscle tissue in normal controls and subjects with 
fibromyalgia syndrome. Pain. 2003;102(1):87-95. 
59. Lemming D, Sörensen J, Gerdle B, Graven-Nielsen T, Arendt-Nielsen L. Widespread pain 
hypersensitivity and facilitated temporal summation of deep tissue pain in whiplash 
associated disorder: An explorative study of women. Journal of Rehabilitation Medicine. 
2012;44(8):648-657. 
60. Yarnitsky D, Arendt-Nielsen L, Bouhassira D, Edwards RR, Fillingim RB, Granot M, et al. 
Recommendations on terminology and practice of psychophysical DNIC testing. European 
Journal of Pain. 2010;14(4):339-339. 
61. Imai Y, Petersen KK, Mørch CD, Arendt Nielsen L. Comparing test–retest reliability and 
magnitude of conditioned pain modulation using different combinations of test and 
conditioning stimuli. Somatosensory and Motor Research. 2016;33(3-4):169-177. 
62. Pud D, Granovsky Y, Yarnitsky D. The methodology of experimentally induced diffuse noxious 
inhibitory control (DNIC)-like effect in humans. Pain. 2009;144(1-2):16-19. 
63. Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): 
its relevance for acute and chronic pain states. Current Opinion in Anaesthesiology. 
2010;23(5):611-615. 
64. Graven‐Nielsen T, Izumi M, Petersen KK, Arendt‐Nielsen L. User‐independent assessment of 
conditioning pain modulation by cuff pressure algometry. European Journal of Pain. 
2017;21(3):552-561. 
65. Yarnitsky D, Crispel Y, Eisenberg E, Granovsky Y, Ben-Nun A, Sprecher E, et al. Prediction of 
chronic post-operative pain: Pre-operative DNIC testing identifies patients at risk. Pain. 
2008;138(1):22-28. 
66. Yarnitsky D, Bouhassira D, Drewes AM, Fillingim RB, Granot M, Hansson P, et al. 
Recommendations on practice of conditioned pain modulation (CPM) testing. European 
Journal of Pain. 2015;19(6):805-806. 
67. Yarnitsky D. Role of endogenous pain modulation in chronic pain mechanisms and treatment. 
Pain. 2015;156 Suppl 1:S24. 
68. Kosek E, Ordeberg G. Lack of pressure pain modulation by heterotopic noxious conditioning 
stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. 
Pain. 2000;88(1):69-78. 
69. King CD, Wong F, Currie T, Mauderli AP, Fillingim RB, Riley JL. Deficiency in endogenous 
modulation of prolonged heat pain in patients with Irritable Bowel Syndrome and 
Temporomandibular Disorder. Pain. 2009;143(3):172-178. 
70. Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clinical 
Journal of Pain. 1997;13(3):189-196. 
71. van Wijk G, Veldhuijzen DS. Perspective on Diffuse Noxious Inhibitory Controls as a Model of 
Endogenous Pain Modulation in Clinical Pain Syndromes. Journal of Pain. 2010;11(5):408-419. 
72. Rathleff MS. Impaired Conditioned Pain Modulation in Young Female Adults with Long-
Standing Patellofemoral Pain: A Single Blinded Cross-Sectional Study. Pain Medicine. 
2016;17(5):980-989. 
73. Petersen KK, Arendt-Nielsen L, Finocchietti S, Hirata RP, Simonsen O, Laursen MB, Graven-
Nielsen T. Age Interactions on Pain Sensitization in Patients with Severe Knee Osteoarthritis 
and Controls. Clin J Pain. 2017. 
74. Amris K, Wæhrens EE, Jespersen A, Stockmarr A, Bennett R, Bliddal H, Danneskiold-
Samsøe B. The Relationship between Mechanical Hyperalgesia Assessed by Manual Tender 
Point Examination and Disease Severity in Patients with Chronic Widespread Pain: A Cross-
Sectional Study. International Journal of Rheumatology. 2014;2014. 
75. Vaegter HB, Handberg G, Emmeluth C, Graven-Nielsen T. Preoperative Hypoalgesia After Cold 
Pressor Test and Aerobic Exercise is Associated With Pain Relief 6 Months After Total Knee 
Replacement. The Clinical Journal of Pain. 2017;33(6):475-484. 
76. Petersen KK, Graven-Nielsen T, Simonsen O, Laursen MB, Arendt-Nielsen L. Preoperative pain 
mechanisms assessed by cuff algometry are associated with chronic postoperative pain relief 
after total knee replacement. Pain. 2016;157(7):1400. 
77. Henriksen M, Klokker L, Graven‐Nielsen T, Bartholdy C, Schjødt Jørgensen T, Bandak E, et 
al. Association of Exercise Therapy and Reduction of Pain Sensitivity in Patients With Knee 
Osteoarthritis: A Randomized Controlled Trial. Arthritis Care &amp; Research. 
2014;66(12):1836-1843. 
78. Skou ST, Graven-Nielsen T, Rasmussen S, Simonsen OH, Laursen MB, Arendt-Nielsen L. 
Widespread sensitization in patients with chronic pain after revision total knee arthroplasty. 
Pain. 2013;154(9):1588-1594. 
79. Skou ST, Graven-Nielsen T, Lengsoe L, Arendt-Nielsen L, Simonsen O, Laursen MB. Relating 
clinical measures of pain with experimentally assessed pain mechanisms in patients with knee 
osteoarthritis. Scandinavian Journal of Pain. 2013;4(2):111-117. 
80. Vaegter HB, Handberg G, Graven-Nielsen T. Hypoalgesia after Exercise and the Cold Pressor 
Test is Reduced in Chronic Musculoskeletal Pain Patients with High Pain Sensitivity. Clinical 
Journal of Pain. 2016;32(1):58-69. 
81. Vaegter HB, Palsson TS, Graven-Nielsen T. Facilitated Pro-Nociceptive Pain Mechanisms in 
Radiating Back Pain Compared with Localized Back Pain. Journal of Pain. 2017. 
82. Vaegter HB, Graven-Nielsen T. Pain modulatory phenotypes differentiate subgroups with 
different clinical and experimental pain sensitivity. Pain. 2016;157(7):1480. 
83. Polianskis R, Graven-Nielsen T, Arendt-Nielsen L. Spatial and temporal aspects of deep tissue 
pain assessed by cuff algometry. Pain. 2002;100(1):19-26. 
84. Stekelenburg A, Oomens C, Bader D. Compression-induced tissue damage: animal models. In: 
Pressure ulcer research. Springer; 2005:187-204. 
85. Mak AFT, Zhang M, Tam EWC. Biomechanics of Pressure Ulcer in Body Tissues Interacting with 
External Forces during Locomotion. Annual Review of Biomedical Engineering. 2010;12:29-53. 
86. de Kruif BJ, Schmidhauser E, Stadler KS, amp, Apos, Sullivan LW. Simulation Architecture for 
Modelling Interaction Between User and Elbow-articulated Exoskeleton. Journal of Bionic 
Engineering. 2017;14(4):706-715. 
87. Zhou L, Li Y, Bai S. A human-centered design optimization approach for robotic exoskeletons 
through biomechanical simulation. Robotics and Autonomous Systems. 2017;91:337-347. 
88. Andersen MS, Yang J, de Zee M, Zhou L, Bai S, Rasmussen J. Full-body musculoskeletal 
modeling using dual microsoft kinect sensors and the anybody modeling system. Paper 
presented at: 14th International Symposium on Computer Simulation in Biomechanics2013; 
Natal, Brazil. 
89. Silva P, Silva M, Martins J. Evaluation of the contact forces developed in the lower 
limb/orthosis interface for comfort design. Multibody System Dynamics. 2010;24(3):367-388. 
90. Breuls R, Bouten C, Oomens C, Bader D, Baaijens F. Compression Induced Cell Damage in 
Engineered Muscle Tissue: An In Vitro Model to Study Pressure Ulcer Aetiology. Annals of 
Biomedical Engineering. 2003;31(11):1357-1364. 
91. Kanaya K, Ogata K, Nakayama T, Ono E, Umezu M. Buttock dummy with force sensors for 
assessment of deep tissue injury risk. Paper presented at: SII 2016 - 2016 IEEE/SICE 
International Symposium on System Integration2017. 
92. Crenshaw AG, Hargens AR, Gershuni DH, Rydevik B. Wide tourniquet cuffs more effective at 
lower inflation pressures. Acta orthopaedica Scandinavica. 1988;59(4):447. 
93. Huysamen K, de Looze M, Bosch T, Ortiz J, Toxiri S, O'Sullivan LW. Assessment of an active 
industrial exoskeleton to aid dynamic lifting and lowering manual handling tasks. Applied 
Ergonomics. 2018;68:125-131. 
94. Ernst M, Lee MHM, Dworkin B, Zaretsky HH. Pain perception decrement produced through 
repeated stimulation. Pain. 1986;26(2):221-231. 
95. Manafi Khanian B, Arendt-Nielsen L, Kjær Petersen K, Samani A, Graven-Nielsen T. Interface 
Pressure Behavior During Painful Cuff Algometry. Pain Medicine (Malden, Mass). 
2016;17(5):915-923. 
 
 
